Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS‐CoV‐2 infection: an IG‐IBD study-Reference-Cited by-同舟云学术

Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS‐CoV‐2 infection: an IG‐IBD study

Published:2021-10-25 Issue:11-12 Volume:54 Page:1432-1441
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Bezzio Cristina¹^ORCID,Armuzzi Alessandro²,Furfaro Federica³,Ardizzone Sandro⁴,Milla Monica⁵,Carparelli Sonia⁶,Orlando Ambrogio⁷,Caprioli Flavio Andrea⁴,Castiglione Fabiana⁸,Viganò Chiara⁹,Ribaldone Davide Giuseppe¹⁰,Zingone Fabiana¹¹,Monterubbianesi Rita²,Imperatore Nicola⁸^ORCID,Festa Stefano²^ORCID,Daperno Marco¹⁰,Scucchi Ludovica²,Ferronato Antonio¹²,Pastorelli Luca⁴,Balestrieri Paola²,Ricci Chiara¹³^ORCID,Cappello Maria⁷,Felice Carla¹⁴,Fiorino Gionata³,Saibeni Simone¹^ORCID,Coppini Francesca,Alvisi Patrizia,Gerardi Viviana,Variola Angela,Mazzuoli Silvia,Lenti Marco Vincenzo,Pugliese Daniela,Allocca Mariangela,Ferretti Francesca,Roselli Jenny,Bossa Fabrizio,Giuliano Alessandra,Piazza Nicole,Manes Gianpiero,Sartini Alessandro,Buda Andrea,Micheli Federica,Ciardo Valeria,Casella Giovanni,Viscido Angelo,Bodini Giorgia,Casini Valentina,Soriano Alessandra,Amato Arnaldo,Grossi Laurino,Onali Sara,Rottoli Matteo,Spagnuolo Rocco,Baroni Stefania,Cortelezzi Claudio Camillo,Baldoni Monia,Vernero Marta,Scaldaferri Franco,Maconi Giovanni,Guarino Alessia Dalila,Palermo Andrea,D'Incà Renata,Scribano Maria Lia,Biancone Livia,Carrozza Lucio,Ascolani Marta,Costa Francesco,Di Sabatino Antonio,Zammarchi Irene,Gottin Matteo,Conforti Francesco Simone,

Affiliation:

1. Rho (Milan) Italy

2. Rome Italy

3. Rozzano (Milan) Italy

4. Milan Italy

5. Florence Italy

6. San Giovanni Rotondo Italy

7. Palermo Italy

8. Naples Italy

9. Monza Italy

10. Turin Italy

11. Padua Italy